Bibliography
- IMS Health. A leading provider of information, services and technology for the healthcare industry around the world. Knowledge Link database. Available from: http://www.imshealth.com/
- Harrison C. The patent cliff steepens. Nat Rev Drug Discov 2011;10(1):12-13
- Gareth M. More patent protection for medicines with a new purpose. Nature 2010;465(7301):1005
- Reitzig M, Ramb F. Who do you trust while bubbles grow and blow? A comparative analysis of the explanatory power of accounting and patent information for the market values of German firms: Deutsche Bundesbank Research Centre; 2004
- Hu YJ, Bian Y, Wang YT. Opening the black box of pharmaceutical patent value: an empirical analysis. Drug Inf J 2008;42:561-8
- Sternitzke C. Knowledge sources, patent protection, and commercialization of pharmaceutical innovations. Res Policy 2010;39(6):810-21
- Trappey AJC, Trappey CV, Wu CY, et al. A patent quality analysis for innovative technology and product development. Adv Eng Inform 2012;26(1):26-34
- Mann RJ, Underweiser M. A new look at patent quality: relating patent prosecution to validity. J Empir Leg Stud 2012;9(1):1-32
- Hall BH, Jaffe A, Trajtenberg M. Market value and patent citations. Rand J Econ 2005;36:16-38
- Chen YS, Chang KC. Exploring the nonlinear effects of patent citations, patent share and relative patent position on market value in the US pharmaceutical industry. Technol Anal Strat Manag 2010;22(2):153-69
- Chen YS, Chang KC. The relationship between a firm's patent quality and its market value — the case of US pharmaceutical industry. Technol Forecast Soc Change 2010;77(1):20-33
- Chen YS, Chang KC. Using neural network to analyze the influence of the patent performance upon the market value of the US pharmaceutical companies. Scientometrics 2009;80(3):637-55
- Mogee ME, Kolar RG. Patent co-citation analysis of Eli Lilly & Co. patents. Expert Opin Ther Pat 1999;9(3):291-305
- Hall BH, Jaffe AB, Trajtenberg M. The NBER Patent Citation Data File: Lessons, Insights and Methodological Tools. National Bureau of Economic Research Working Paper Series 2001; No. 8498
- Lanjouw JO, Schankerman M. Characteristics of patent litigation: a window on competition. RAND J Econ 2001;32(1):129-51
- Lai YH, Che HC. Modeling patent legal value by extension neural network. Expert Syst Appl 2009;36(7):10520-8
- Cook T. Developing trends in pharmaceutical patent claims. Expert Opin Ther Pat 1999;9(5):635-43
- Reitzig M. Improving patent valuations for management purposes—validating new indicators by analyzing application rationales. Res Policy 2004;33(6-7):939-57
- Harhoff D, Scherer FM, Vopel K. Citations, family size, opposition and the value of patent rights. Res Policy 2003;32(8):1343-63
- Lanjouw JO, Schankerman M. Patent Quality and research productivity: measuring innovation with multiple indicators. Econ J 2004;114(495):441-65
- Harhoff D, Narin F, Scherer FM, Vopel K. Citation frequency and the value of patented inventions. Rev Econ Stat 1999;81(3):511-15
- Lanjouw JO, Schankerman M. The quality of ideas: measuring innovation with multiple indicators. NBER Working Paper 1999
- Putnam JD. The value of international patent rights. Yale University, Yale; 1996
- Rivette KG, Kline D. Discovering new value in intellectual property. Harv Bus Rev 2000;January-February:54-66
- Reitzig M. Valuing patents and patent portfolios from a corporate perspective: theoretical considerations, applied needs and future challenges. Edward Elgar Publishing Ltd, Cheltenham; 2006
- Zhang SK, Hu YJ, Yin H, Wang YT. Drug targets and economic value an empirical study based on new drugs marketed in US during recent ten years. Sci Technol Manag Res 2011;31(23):4
- Lu JJ, Pan W, Hu YJ, Wang YT. Multi-target drugs: the trend of drug research and development. PLoS One 2012;7(6):e40262
- Suhrcke M, Nugent R, Stuckler D, Rocco L. Chronic disease: an economic perspective. Oxford Health Alliance, London; 2006
- Wieringa JE, Leeflang PSH. Modeling the effects of promotion expenditures on sales of pharmaceuticals. Appl Econ 2013;45(24):3389-9
- Patel D, Ward MR. Using patent citation patterns to infer innovation market competition. Res Policy 2011;40(6):886-94
- Harhoff D, Reitzig M. Determinants of opposition against EPO patent grants—the case of biotechnology and pharmaceuticals. Int J Ind Organ 2004;22(4):443-80
- Yoshikane F, Suzuki Y, Tsuji K. Analysis of the relationship between citation frequency of patents and diversity of their backward citations for Japanese patents. Scientometrics 2012;92(3):721-33
- Coles PA, Hagiu A, Wagonfeld AB. Ocean Tomo: Building a Market for Intellectual Property. Harvard Business School Case 709-404. 2009. Available from: http://www.hbs.edu/faculty/Pages/item.aspx?num=36385 [Last accessed 28 January 2013]